星形胶质细胞
小胶质细胞
医学
胶质纤维酸性蛋白
脑出血
神经炎症
白细胞介素
促炎细胞因子
中枢神经系统
免疫学
病理
细胞因子
内分泌学
炎症
内科学
免疫组织化学
蛛网膜下腔出血
作者
Samuel Shi,Yujing Li,Kaibin Shi,Kristofer Wood,Andrew F. Ducruet,Qiang Liu
出处
期刊:Stroke
[Lippincott Williams & Wilkins]
日期:2020-02-05
卷期号:51 (3): 967-974
被引量:93
标识
DOI:10.1161/strokeaha.119.028638
摘要
Background and Purpose- Microglia are among the first cells to respond to intracerebral hemorrhage (ICH), but the mechanisms that underlie their activity following ICH remain unclear. IL (interleukin)-15 is a proinflammatory cytokine that orchestrates homeostasis and the intensity of the immune response following central nervous system inflammatory events. The goal of this study was to investigate the role of IL-15 in ICH injury. Methods- Using brain slices of patients with ICH, we determined the presence and cellular source of IL-15. A transgenic mouse line with targeted expression of IL-15 in astrocytes was generated to determine the role of astrocytic IL-15 in ICH. The expression of IL-15 was controlled by a glial fibrillary acidic protein promoter (GFAP-IL-15tg). ICH was induced by intraparenchymal injection of collagenase or autologous blood. Results- In patients with ICH and wild-type mice subjected to experimental ICH, we found a significant upregulation of IL-15 in astrocytes. In GFAP-IL-15tg mice, we found that astrocyte-targeted expression of IL-15 exacerbated brain edema and neurological deficits following ICH. This aggravated ICH injury in GFAP-IL-15tg mice is accompanied by increased microglial accumulation in close proximity to astrocytes in perihematomal tissues. Additionally, microglial expression of CD86, IL-1β, and TNF-α is markedly increased in GFAP-IL-15tg mice following ICH. Furthermore, depletion of microglia using a colony stimulating factor 1 receptor inhibitor diminishes the exacerbation of ICH injury in GFAP-IL-15tg mice. Conclusions- Our findings identify IL-15 as a mediator of the crosstalk between astrocytes and microglia that exacerbates brain injury following ICH.
科研通智能强力驱动
Strongly Powered by AbleSci AI